In animal studies, doses are typically scaled by body weight at approximately 110 mcg/kg
Telomere shortening is one hallmark of aging among many (genomic instability, epigenetic drift, mitochondrial dysfunction, cellular senescence, loss of proteostasis, stem-cell exhaustion, and others), and the relationship between telomere length, telomerase activity, healthspan, and cancer risk is complex and bidirectional in several mammalian settings, more telomerase means more, not less, cancer
According to the American Association of Clinical Endocrinologists and American College of Endocrinology (AACE/ACE) Obesity Clinical Practice Guidelines, all patients undergoing weight loss therapy should be monitored for mood disorders, depression, and suicidal ideation
These risk factors include: Affected individuals may also develop other autoimmune disorders especially Addison disease, autoimmune thyroid disease (both hyperthyroidism and hypothyroidism), diabetes mellitus, pernicious anaemia and alopecia areata